Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
2020 ◽
Vol 51
(3)
◽
pp. 544-560
◽
Keyword(s):